Review Article
Treatment and case fatality rate of COVID-19 in Africa
Submitted: 11 April 2024 | Published: 07 September 2022
About the author(s)
Ben Bepouka, Service of Infectious Diseases, Department of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Congo, the Democratic Republic of thePatricia Bandubuila Kaja, Service of Infectious Diseases, Department of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Congo, the Democratic Republic of the
Hippolyte Situakibanza, Service of Infectious Diseases, Department of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Congo, the Democratic Republic of the
Full Text:
PDF (2MB)Abstract
In Africa, the treatment of COVID-19 depends on each country. Several protocols are observed with real results that we described in this study. The objective of this review was to describe the treatment of COVID-19 and the case fatality rate in African countries, by reviewing the literature on treatment and case fatality in African countries whose data was available through the internet during the writing period until February 7, 2021. The majority of African countries had a treatment based on hydroxychloroquine or chloroquine + azithromycin, used in varying doses depending on the country. The lethality in Africa remains low compared to European and American countries. The same treatment being used in some northern countries does not fully explain the low case fatality.
Keywords
Metrics
Total abstract views: 1499Total article views: 103